Quest for the right Drug
וארדנאפיל אינובמד 20 מ"ג VARDENAFIL INOVAMED 20 MG (VARDENAFIL AS HYDROCHLORIDE TRIHYDRATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליות מצופות פילם : FILM COATED TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Summary of the safety profile The adverse reactions reported with Vardenafil Inovamed film-coated tablets in clinical trials were generally transient and mild to moderate in nature. The most commonly reported adverse drug reaction occurring in ≥ 10% of patients is headache. Tabulated list of adverse reactions Adverse reactions are listed according to the MedDRA frequency convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and not known (can not be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. The following adverse reactions have been reported: System Organ very Common Uncommon Rare Not known Class common (≥1/100 to (≥1/1,000 to <1/100) (≥1/10,000 to (cannot be (≥1/10) <1/10) <1/1,000) estimated from the available data) Infection and Conjunctivitis infestations Immune system Allergic Allergic reaction disorders oedema and angioedema Psychiatric Sleep disorder Anxiety disorders Nervous system Headache Dizziness Somnolence Syncope Cerebral disorders Paraesthesia Seizure haemorrhage and Amnesia dysaesthesia Transient ischaemic attack Eye disorders Visual disturbance Increase in Non-arteritic Ocular hyperaemia intraocular anterior Visual colour pressure ischemic distortions optic Eye pain and eye Lacrimation neuropathy discomfort increased Visual Photophobia defects Ear and Tinnitus Sudden labyrinth Vertigo deafness disorders Cardiac Palpitation Myocardial Sudden death disorders Tachycardia infarction Ventricular tachy- arrhythmias Angina pectoris Vascular Flushing Hypotension disorders Hypertension Respiratory, Nasal Dyspnoea Epistaxis thoracic and congestion Sinus congestion mediastinal disorders Gastrointestinal Dyspepsia Gastro-oesophageal disorders reflux disease Gastritis Gastrointestinal and abdominal pain Diarrhoea Vomiting Nausea Dry mouth Hepatobiliary Increase in Increase in disorders transaminases gamma-glutamyl transferase Skin and Erythema Photosensitivity subcutaneous Rash reaction tissue disorders Musculoskeletal Back pain and connective Increase in creatine tissue disorders phosphokinase Myalgia Increased muscle tone and cramping Renal and Haematuria urinary disorders Reproductive Increase in erection Priapism Penile system and Haemorrhage breast disorders Haematosper- mia General Feeling unwell Chest pain disorders and administration site conditions Description of selected adverse reactions Penile haemorrhage, haematospermia and haematuria have been reported in clinical trials and spontaneous post-marketing data with the use of all PDE5 inhibitors, including vardenafil. At a dose of 20 mg Vardenafil Inovamed film-coated tablets, elderly (≥65 years old) patients had higher frequencies of headaches (16.2% versus 11.8%) and dizziness (3.7% versus 0.7%) than younger patients (<65 years old). In general, the incidence of adverse reactions (especially “dizziness”) has been shown to be slightly higher in patients with a history of hypertension. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף